Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer
FranceStudy on Baricitinib for Treating Large Inflammatory Liver Adenomas in Women and Non-Resectable Cases in Men
FranceStudy on the Safety and Effectiveness of GSKVX000000008866 and GSKVX000000009151 in Adults with Chronic Hepatitis B on Nucleotide Analogue Therapy
BelgiumStudy on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis
BelgiumStudy on the Safety and Effectiveness of 166Holmium Radiation Therapy with Atezolizumab and Bevacizumab for Patients with Non-Resectable Liver Cancer
FranceStudy of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes
BelgiumStudy on Gene Therapy with VTX-801 and Copper (64Cu) Chloride for Adults with Wilson's Disease
DenmarkStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
BelgiumStudy Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema
DenmarkStudy on Advanced Liver Cancer: Evaluating Livmoniplimab and Budigalimab in Patients Without Prior Systemic Treatment
FranceStudy of Nivolumab, Relatlimab and Bevacizumab combination for patients with untreated advanced or metastatic liver cancer (hepatocellular carcinoma)
FranceStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
BelgiumThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
